Short answer
Oscar Health, Inc. (OSCR) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Oscar Health announced financial results for Q3 2026, quarter ended September 30, 2026.
Oscar Health, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Oscar Health announced financial results for Q3 2026, quarter ended September 30, 2026
- Full results and management commentary appear in Exhibit 99.1, the accompanying earnings release
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $5.14B, up from $2.99B, driven by rate increases, membership growth and a $250M risk-adjustment benefit
- Operating earnings $178.0M versus a $129.3M loss, with MLR improving to 84.0% from 88.5% and SG&A ratio to 14.0% from 17.5%
- Net income $167.3M, or $0.49 diluted EPS, versus a $137.5M loss, while adjusted EBITDA reached $206.9M
- Effectuated membership increased to 2.69M from 2.12M, supporting scale but increasing exposure to medical-cost and risk-adjustment execution
- Full-year outlook raised: revenue $19.0B-$19.3B and operating earnings $850M-$950M, versus prior ranges of $18.7B-$19.0B and $600M-$800M
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Oscar Health, Inc. 8-K filings
Get the next OSCR 8-K as it lands
Follow OSCR for push alerts, or ask the research agent what this filing means.